dry%20eye%20syndrome
DRY EYE SYNDROME

Dry eye syndrome is a clinical condition wherein the patient experiences ocular and conjunctival irritation due to decreased tear production and/or excessive tear evaporation.
It is associated with increased osmolarity of the tear film and inflammation of the ocular surface.

Goal of treatments are to relieve symptoms of patients, to improve visual acuity & quality of life of patients, to restore ocular surface & tear film to normal homeostatic state and to correct the underlying defect.

Follow Up

  • The patient is advised to follow up, in order to assess their response to therapy, if there is a need to alter or adjust the treatment & to monitor structural ocular damage, as well as to provide reassurance
  • Frequency & extent of follow-up will depend on the severity of the disease, therapeutic approach & response to therapy

Counselling

  • Clinicians should provide their patients w/ proper instructions for their therapeutic regimens, as well as caution them about LASIK, as this may worsen their dry eye condition
    • May refer their patients to an appropriate specialist, if there are other causes or underlying conditions that would contribute to having dry eye 
  • Patients should be educated about the chronic nature of the disease & its process
    • Their compliance, understanding of the disease, risks for structural changes should periodically be reassessed
Editor's Recommendations
Most Read Articles
3 days ago
Children with high dental anxiety are more likely to develop dental diseases, which, in turn, negatively affect the family’s quality of life, a recent study has found.
2 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
6 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
3 days ago
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.